Annual EBIT:
$195.12M+$108.31M(+124.77%)Summary
- As of today, CPRX annual earnings before interest & taxes is $195.12 million, with the most recent change of +$108.31 million (+124.77%) on December 31, 2024.
- During the last 3 years, CPRX annual EBIT has risen by +$142.74 million (+272.48%).
- CPRX annual EBIT is now at all-time high.
Performance
CPRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$66.27M-$31.00K(-0.05%)Summary
- As of today, CPRX quarterly earnings before interest & taxes is $66.27 million, with the most recent change of -$31.00 thousand (-0.05%) on September 30, 2025.
- Over the past year, CPRX quarterly EBIT has increased by +$15.36 million (+30.17%).
- CPRX quarterly EBIT is now -0.05% below its all-time high of $66.30 million, reached on June 30, 2025.
Performance
CPRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$258.77M+$15.36M(+6.31%)Summary
- As of today, CPRX TTM earnings before interest & taxes is $258.77 million, with the most recent change of +$15.36 million (+6.31%) on September 30, 2025.
- Over the past year, CPRX TTM EBIT has increased by +$84.80 million (+48.74%).
- CPRX TTM EBIT is now at all-time high.
Performance
CPRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CPRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +124.8% | +30.2% | +48.7% |
| 3Y3 Years | +272.5% | +164.0% | +208.9% |
| 5Y5 Years | +513.1% | +466.2% | +535.9% |
CPRX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +272.5% | -0.1% | +278.2% | at high | +240.8% |
| 5Y | 5-Year | at high | +513.1% | -0.1% | +278.2% | at high | +540.5% |
| All-Time | All-Time | at high | +652.8% | -0.1% | +278.2% | at high | +833.2% |
CPRX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $66.27M(-0.0%) | $258.77M(+6.3%) |
| Jun 2025 | - | $66.30M(+4.6%) | $243.42M(+5.2%) |
| Mar 2025 | - | $63.37M(+0.8%) | $231.37M(+18.6%) |
| Dec 2024 | $195.12M(+124.8%) | $62.84M(+23.4%) | $195.12M(+12.2%) |
| Sep 2024 | - | $50.91M(-6.2%) | $173.97M(+102.6%) |
| Jun 2024 | - | $54.25M(+100.0%) | $85.88M(+9.6%) |
| Mar 2024 | - | $27.13M(-34.9%) | $78.33M(-9.8%) |
| Dec 2023 | $86.81M(-14.8%) | $41.69M(+212.1%) | $86.81M(+14.3%) |
| Sep 2023 | - | -$37.19M(-179.6%) | $75.92M(-45.1%) |
| Jun 2023 | - | $46.70M(+31.1%) | $138.21M(+15.1%) |
| Mar 2023 | - | $35.61M(+15.6%) | $120.08M(+17.9%) |
| Dec 2022 | $101.84M(+94.4%) | $30.80M(+22.7%) | $101.84M(+21.6%) |
| Sep 2022 | - | $25.10M(-12.1%) | $83.78M(+15.3%) |
| Jun 2022 | - | $28.57M(+64.5%) | $72.68M(+21.2%) |
| Mar 2022 | - | $17.37M(+36.3%) | $59.95M(+14.4%) |
| Dec 2021 | $52.38M(+26.8%) | $12.74M(-9.0%) | $52.38M(+8.5%) |
| Sep 2021 | - | $14.00M(-11.6%) | $48.26M(+5.0%) |
| Jun 2021 | - | $15.84M(+61.6%) | $45.96M(+13.8%) |
| Mar 2021 | - | $9.80M(+13.7%) | $40.40M(-2.2%) |
| Dec 2020 | $41.30M(+29.8%) | $8.62M(-26.4%) | $41.30M(+1.5%) |
| Sep 2020 | - | $11.70M(+13.8%) | $40.69M(-5.0%) |
| Jun 2020 | - | $10.28M(-3.9%) | $42.83M(-1.6%) |
| Mar 2020 | - | $10.70M(+33.6%) | $43.51M(+36.7%) |
| Dec 2019 | $31.82M(+190.2%) | $8.01M(-42.2%) | $31.82M(+254.6%) |
| Sep 2019 | - | $13.85M(+26.3%) | $8.97M(+168.7%) |
| Jun 2019 | - | $10.96M(+1209.5%) | -$13.05M(+57.0%) |
| Mar 2019 | - | -$987.80K(+93.3%) | -$30.35M(+14.0%) |
| Dec 2018 | -$35.30M(-89.0%) | -$14.84M(-81.4%) | -$35.30M(-35.9%) |
| Sep 2018 | - | -$8.18M(-29.1%) | -$25.96M(-17.5%) |
| Jun 2018 | - | -$6.34M(-6.8%) | -$22.09M(-10.8%) |
| Mar 2018 | - | -$5.93M(-7.6%) | -$19.93M(-6.7%) |
| Dec 2017 | -$18.68M(+3.1%) | -$5.51M(-28.0%) | -$18.68M(-6.9%) |
| Sep 2017 | - | -$4.31M(-3.0%) | -$17.48M(-2.3%) |
| Jun 2017 | - | -$4.18M(+10.7%) | -$17.09M(+3.6%) |
| Mar 2017 | - | -$4.68M(-8.5%) | -$17.72M(+8.1%) |
| Dec 2016 | -$19.28M(+5.5%) | -$4.31M(-10.2%) | -$19.28M(+8.9%) |
| Sep 2016 | - | -$3.91M(+18.7%) | -$21.16M(+5.0%) |
| Jun 2016 | - | -$4.81M(+22.8%) | -$22.26M(+0.4%) |
| Mar 2016 | - | -$6.24M(-0.7%) | -$22.34M(-9.5%) |
| Dec 2015 | -$20.40M(-39.8%) | -$6.19M(-23.4%) | -$20.40M(-12.1%) |
| Sep 2015 | - | -$5.02M(-2.5%) | -$18.19M(-5.3%) |
| Jun 2015 | - | -$4.90M(-14.1%) | -$17.28M(-12.4%) |
| Mar 2015 | - | -$4.29M(-7.7%) | -$15.38M(-5.4%) |
| Dec 2014 | -$14.59M | -$3.98M(+3.0%) | -$14.59M(-9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | -$4.11M(-37.4%) | -$13.31M(-6.9%) |
| Jun 2014 | - | -$2.99M(+14.8%) | -$12.45M(-2.8%) |
| Mar 2014 | - | -$3.51M(-29.6%) | -$12.11M(-17.5%) |
| Dec 2013 | -$10.31M(-97.5%) | -$2.71M(+16.6%) | -$10.31M(-13.2%) |
| Sep 2013 | - | -$3.25M(-22.3%) | -$9.11M(-27.4%) |
| Jun 2013 | - | -$2.65M(-55.6%) | -$7.15M(-28.5%) |
| Mar 2013 | - | -$1.71M(-13.3%) | -$5.56M(-6.5%) |
| Dec 2012 | -$5.22M(+14.2%) | -$1.51M(-17.3%) | -$5.22M(+9.2%) |
| Sep 2012 | - | -$1.28M(-20.3%) | -$5.75M(-2.7%) |
| Jun 2012 | - | -$1.07M(+21.8%) | -$5.60M(+5.6%) |
| Mar 2012 | - | -$1.36M(+32.9%) | -$5.93M(+2.5%) |
| Dec 2011 | -$6.08M(-51.1%) | -$2.03M(-79.9%) | -$6.08M(-15.4%) |
| Sep 2011 | - | -$1.13M(+19.1%) | -$5.27M(-4.4%) |
| Jun 2011 | - | -$1.40M(+8.0%) | -$5.05M(-1.3%) |
| Mar 2011 | - | -$1.52M(-24.4%) | -$4.98M(-10.4%) |
| Dec 2010 | -$4.02M(+44.7%) | -$1.22M(-34.4%) | -$4.51M(-1.2%) |
| Sep 2010 | - | -$908.50K(+31.9%) | -$4.46M(+7.9%) |
| Jun 2010 | - | -$1.33M(-26.9%) | -$4.85M(+8.3%) |
| Mar 2010 | - | -$1.05M(+10.2%) | -$5.28M(+27.4%) |
| Dec 2009 | -$7.28M(+33.2%) | -$1.17M(+9.5%) | -$7.28M(+26.5%) |
| Sep 2009 | - | -$1.29M(+26.9%) | -$9.90M(+14.1%) |
| Jun 2009 | - | -$1.77M(+41.9%) | -$11.52M(+5.7%) |
| Mar 2009 | - | -$3.04M(+19.7%) | -$12.21M(-12.1%) |
| Dec 2008 | -$10.89M(-116.7%) | -$3.79M(-30.1%) | -$10.89M(-32.1%) |
| Sep 2008 | - | -$2.91M(-18.3%) | -$8.25M(-31.3%) |
| Jun 2008 | - | -$2.46M(-42.9%) | -$6.28M(-19.5%) |
| Mar 2008 | - | -$1.72M(-50.9%) | -$5.25M(-4.5%) |
| Dec 2007 | -$5.03M(-73.2%) | -$1.14M(-20.2%) | -$5.03M(-5.4%) |
| Sep 2007 | - | -$950.40K(+33.9%) | -$4.77M(+7.6%) |
| Jun 2007 | - | -$1.44M(+4.0%) | -$5.16M(-38.6%) |
| Mar 2007 | - | -$1.50M(-69.1%) | -$3.72M(-67.2%) |
| Dec 2006 | -$2.90M(-59.3%) | -$885.20K(+34.0%) | -$2.23M(+16.4%) |
| Sep 2006 | - | -$1.34M(>-9900.0%) | -$2.66M(-70.4%) |
| Jun 2006 | - | $0.00(0.0%) | -$1.56M(+29.7%) |
| Mar 2006 | - | $0.00(+100.0%) | -$2.22M(+22.9%) |
| Dec 2005 | -$1.82M(-235.6%) | -$1.32M(-446.4%) | -$2.89M(-69.9%) |
| Sep 2005 | - | -$241.90K(+63.4%) | -$1.70M(-6.7%) |
| Jun 2005 | - | -$660.80K(0.0%) | -$1.59M(-49.3%) |
| Mar 2005 | - | -$660.80K(-389.5%) | -$1.07M(-97.4%) |
| Dec 2004 | -$543.00K(-26.7%) | -$135.00K(0.0%) | -$540.00K(-33.3%) |
| Sep 2004 | - | -$135.00K(0.0%) | -$405.00K(-50.0%) |
| Jun 2004 | - | -$135.00K(0.0%) | -$270.00K(-100.0%) |
| Mar 2004 | - | -$135.00K | -$135.00K |
| Dec 2003 | -$428.60K(-67.5%) | - | - |
| Dec 2002 | -$255.90K | - | - |
FAQ
- What is Catalyst Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Catalyst Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Catalyst Pharmaceuticals, Inc.?
- What is Catalyst Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Catalyst Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of CPRX is $195.12M
What is the all-time high annual EBIT for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $195.12M
What is Catalyst Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, CPRX annual earnings before interest & taxes has changed by +$108.31M (+124.77%)
What is Catalyst Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of CPRX is $66.27M
What is the all-time high quarterly EBIT for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $66.30M
What is Catalyst Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, CPRX quarterly earnings before interest & taxes has changed by +$15.36M (+30.17%)
What is Catalyst Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of CPRX is $258.77M
What is the all-time high TTM EBIT for Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $258.77M
What is Catalyst Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, CPRX TTM earnings before interest & taxes has changed by +$84.80M (+48.74%)